Galina Vorobeychik

2.0k total citations
14 papers, 620 citations indexed

About

Galina Vorobeychik is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Galina Vorobeychik has authored 14 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Galina Vorobeychik's work include Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (4 papers) and Immune Cell Function and Interaction (3 papers). Galina Vorobeychik is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (4 papers) and Immune Cell Function and Interaction (3 papers). Galina Vorobeychik collaborates with scholars based in Canada, United States and United Kingdom. Galina Vorobeychik's co-authors include A. Dessa Sadovnick, V. Devonshire, А. Н. Бойко, D. W. Paty, David K.B. Li, Donald W. Paty, Kenneth P. Whittall, Alex L. MacKay, Irene M. Vavasour and Andrew Riddehough and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Neurology.

In The Last Decade

Galina Vorobeychik

13 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Galina Vorobeychik Canada	8	413	162	133	97	90	14	620
Rana Zabad United States	16	333 0.8×	166 1.0×	75 0.6×	60 0.6×	42 0.5×	34	722
Pietro Iaffaldano Italy	18	705 1.7×	197 1.2×	139 1.0×	73 0.8×	32 0.4×	56	898
E. Di Monte Italy	10	554 1.3×	187 1.2×	163 1.2×	42 0.4×	27 0.3×	14	649
John R. Rinker United States	12	295 0.7×	152 0.9×	72 0.5×	51 0.5×	50 0.6×	23	654
Mattias Vågberg Sweden	10	384 0.9×	230 1.4×	73 0.5×	23 0.2×	99 1.1×	14	617
Anton Vladić Croatia	12	452 1.1×	218 1.3×	141 1.1×	32 0.3×	47 0.5×	26	726
A Calò Italy	7	369 0.9×	162 1.0×	86 0.6×	83 0.9×	21 0.2×	8	557
Channa Kolb United States	21	807 2.0×	301 1.9×	199 1.5×	42 0.4×	159 1.8×	50	1.2k
Bruno Brochet France	6	735 1.8×	398 2.5×	190 1.4×	117 1.2×	36 0.4×	12	872
T. Arbizu Spain	15	563 1.4×	216 1.3×	165 1.2×	98 1.0×	20 0.2×	28	745

Countries citing papers authored by Galina Vorobeychik

Since Specialization

Citations

This map shows the geographic impact of Galina Vorobeychik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galina Vorobeychik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galina Vorobeychik more than expected).

Fields of papers citing papers by Galina Vorobeychik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galina Vorobeychik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galina Vorobeychik. The network helps show where Galina Vorobeychik may publish in the future.

Co-authorship network of co-authors of Galina Vorobeychik

This figure shows the co-authorship network connecting the top 25 collaborators of Galina Vorobeychik. A scholar is included among the top collaborators of Galina Vorobeychik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galina Vorobeychik. Galina Vorobeychik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Allanach, Jessica R., et al.. (2025). Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis. Science Advances. 11(10). eadu5110–eadu5110. 1 indexed citations

Freedman, Mark S., Virginia Devonshire, Catherine Larochelle, et al.. (2025). First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1–10.

Allanach, Jessica R., et al.. (2022). Gammaherpesvirus infection drives age-associated B cells toward pathogenicity in EAE and MS. Science Advances. 8(47). eade6844–eade6844. 20 indexed citations

Vorobeychik, Galina, et al.. (2021). A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(3). 3080392874–3080392874. 1 indexed citations

Allanach, Jessica R., Yu Gu, Iryna Shanina, et al.. (2020). Insights into the role of Epstein-Barr virus infection in multiple sclerosis using a novel humanized mouse model of disease. The Journal of Immunology. 204(1_Supplement). 58.9–58.9. 2 indexed citations

Vorobeychik, Galina, et al.. (2020). Multiple Sclerosis and Related Challenges to Young women’s Health: Canadian Expert Review. Neurodegenerative Disease Management. 10(sup2). 1–13. 7 indexed citations

Allanach, Jessica R., et al.. (2020). Latent gammaherpesvirus infection licenses age-associated B cells for pathogenicity during EAE and MS. The Journal of Immunology. 204(1_Supplement). 58.10–58.10. 2 indexed citations

Vorobeychik, Galina, et al.. (2020). Area postrema syndrome: a neurological presentation of nausea, vomiting and hiccups. BMJ Case Reports. 13(11). e238588–e238588. 7 indexed citations

Freedman, Mark S., Pierre Duquette, L. Lee, et al.. (2019). The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis. Current Medical Research and Opinion. 35(5). 767–776. 2 indexed citations

10.

Metz, Luanne M., David K.B. Li, Anthony Traboulsee, et al.. (2017). Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. New England Journal of Medicine. 376(22). 2122–2133. 140 indexed citations

11.

Vorobeychik, Galina, et al.. (2017). Short-Term Motor Learning and Retention During Visually Guided Walking in Persons With Multiple Sclerosis. Neurorehabilitation and neural repair. 31(7). 648–656. 10 indexed citations

12.

Guimond, Colleen, Sreeram V. Ramagopalan, David A. Dyment, et al.. (2014). Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors. Multiple Sclerosis Journal. 20(9). 1182–1188. 22 indexed citations

13.

Бойко, А. Н., Galina Vorobeychik, D. W. Paty, V. Devonshire, & A. Dessa Sadovnick. (2002). Early onset multiple sclerosis. Neurology. 59(7). 1006–1010. 312 indexed citations

14.

Vavasour, Irene M., Kenneth P. Whittall, Alex L. MacKay, et al.. (1998). A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magnetic Resonance in Medicine. 40(5). 763–768. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact